Cannell & Spears’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$40.4M Sell
151,537
-7,025
-4% -$1.9M 0.79% 38
2025
Q4
$39.8M Sell
158,562
-1,018
-0.6% -$270K 0.74% 35
2025
Q3
$45.8M Sell
159,580
-2,938
-2% -$787K 0.86% 32
2025
Q2
$42.7M Sell
162,518
-1,899
-1% -$462K 0.86% 31
2025
Q1
$38.3M Sell
164,417
-38,138
-19% -$9.25M 0.82% 35
2024
Q4
$46.4M Buy
202,555
+32,259
+19% +$7.4M 0.95% 31
2024
Q3
$38.1M Buy
170,296
+4,961
+3% +$1.09M 0.75% 43
2024
Q2
$33.6M Sell
165,335
-177,536
-52% -$36.1M 0.7% 46
2024
Q1
$74.9M Buy
342,871
+337,821
+6,690% +$74.4M 1.55% 11
2023
Q4
$1.15M Hold
5,050
0.09% 90
2023
Q3
$1.02M Sell
5,050
-828
-14% -$175K 0.09% 87
2023
Q2
$1.22M Buy
5,878
+4,819
+455% +$935K 0.1% 82
2023
Q1
$209K Hold
1,059
0.02% 211
2022
Q4
$214K Buy
+1,059
New +$207K 0.02% 210
2022
Q3
Sell
-1,059
Closed -$213K 203
2022
Q2
$213K Hold
1,059
0.02% 194
2022
Q1
$240K Hold
1,059
0.02% 200
2021
Q4
$286K Hold
1,059
0.02% 189
2021
Q3
$256K Sell
1,059
-71
-6% -$17.9K 0.02% 208
2021
Q2
$268K Sell
1,130
-349
-24% -$79.5K 0.02% 208
2021
Q1
$324K Hold
1,479
0.03% 178
2020
Q4
$259K Hold
1,479
0.02% 194
2020
Q3
$239K Sell
1,479
-4
-0.3% -$634 0.02% 194
2020
Q2
$212K Buy
+1,483
New +$205K 0.02% 202

Other funds holding LH

Cannell & Spears's LH Position: Q1 2026 in Review

Cannell & Spears reduced its Labcorp (LH) stake by 4.4% in Q1 2026, selling an estimated $1.9M and leaving 151,537 shares worth $40.4M. The position accounts for 0.79% of the portfolio, ranked #38.

Cannell & Spears first reported a position in LH in Q2 2020 and has held it in 23 quarters since. The position peaked at $74.9M in Q1 2024. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Cannell & Spears held 151,537 shares of Labcorp worth $40.4M as of Q1 2026.
  • Cannell & Spears sold 7,025 Labcorp shares in Q1 2026, an estimated $1.9M.
  • Labcorp made up 0.79% of Cannell & Spears's portfolio in Q1 2026, its #38 holding.
  • Cannell & Spears first reported a position in Labcorp in Q2 2020 and has held it in 23 quarters since.
  • Cannell & Spears's Labcorp position peaked at $74.9M in Q1 2024.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Cannell & Spears's 13F filing for Q1 2026, filed 14 May 2026.